Parmeswaran Diagaradjane

The University of Texas MD Anderson Cancer Center — United States

Engineering · Physical Sciences

27h-index4.0kcitations104works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoplatforms for cancer theranostics(28), Nanoparticle-Based Drug Delivery(15), S100 Proteins and Annexins(12), Gold and Silver Nanoparticles Synthesis and Applications(10), Photodynamic Therapy Research Studies(10)

Publications104 total

Optimizing Motion Management and Baseline Shifts in Magnetic Resonance-Guided Spine Stereotactic Body Radiation Therapy
Cancers·2025Open Access
Comparison of the Radiotherapy Techniques for the Treatment of Ocular Melanoma
Journal of Neurological Surgery Part B Skull Base·2025
Data from A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Figures S1-S3 from Imaging Epidermal Growth Factor Receptor Expression <i>In vivo</i>: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
2023Open Access
Supplementary Data from A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Data from Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine
2023Open Access
Supplementary Figures S1-S3 from Imaging Epidermal Growth Factor Receptor Expression <i>In vivo</i>: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
2023Open Access
Data from Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine
2023Open Access
Supplementary Table 1 from Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine
2023Open Access
Supplementary Table 1 from Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine
2023Open Access
Data from Imaging Epidermal Growth Factor Receptor Expression <i>In vivo</i>: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
2023Open Access
Supplementary Data from A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Data from Imaging Epidermal Growth Factor Receptor Expression <i>In vivo</i>: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
2023Open Access
Data from A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Figure Legends 1-4 from Neutrophil Gelatinase–Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer
2023Open Access
Supplementary Figure 4 from Neutrophil Gelatinase–Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer
2023Open Access
Supplementary Figure 1 from γ-Tocotrienol Inhibits Pancreatic Tumors and Sensitizes Them to Gemcitabine Treatment by Modulating the Inflammatory Microenvironment
2023Open Access
Supplementary Figure 1 from Neutrophil Gelatinase–Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer
2023Open Access
Data from γ-Tocotrienol Inhibits Pancreatic Tumors and Sensitizes Them to Gemcitabine Treatment by Modulating the Inflammatory Microenvironment
2023Open Access
Supplementary Figure 2 from Neutrophil Gelatinase–Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Sunil Krishnan(27), Amit Deorukhkar(18), Sushovan Guha(14), Bharat B. Aggarwal(14), Juri G. Gelovani(11), Ajaikumar B. Kunnumakkara(10), James W. Tunnell(9), Jon A. Schwartz(8), Sunil Krishnan(7), Shujun Shentu(6), Sang Hyun Cho(6), Bahman Anvari(6), Kuzhuvelil B. Harikumar(5), Bokyung Sung(5), Zhimin Tong(5), Mohammad A. Yaseen(5), J. Donald Payne(4), Jie Yu(4), Michael S. Wong(4), Dev Chatterjee(3)